ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Director, Medical Writing at Dyne Therapeutics - ApplyBlast

Director, Medical Writing

Dyne Therapeutics

3 days ago

4.1 on Glassdoor

Remote

Full Time

Director

2 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Director, Medical Writing provides strategic leadership and hands-on execution for developing high-quality, compliant clinical and regulatory documents for one or more development programs. This role partners with cross-functional teams to ensure clear scientific messaging across key submissions to the FDA and global health authorities. The position operates with a high degree of independence to drive document planning, authoring, review, and finalization in alignment with company priorities and regulatory requirements.

Responsibilities

Lead planning and authoring of clinical and regulatory documents for FDA submissions
Manage internal and external medical writing resources to deliver high-quality documents
Review and refine documents to ensure scientific accuracy and regulatory compliance

Skills

About Dyne Therapeutics

dyne-tx.com

Headquarters

Waltham, Massachusetts, United States

Company Size

51-200 employees

Founded

2018

View Profile

Dyne Therapeutics is a biotechnology company developing nucleic acid–based therapies for genetically driven neuromuscular diseases. Leveraging its proprietary FORCE™ platform, Dyne aims to address the root cause of disease and deliver functional improvement for people living with conditions such as Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular dystrophy (FSHD). The company advances a pipeline of therapeutics from discovery through clinical development with the mission of transforming the lives of patients with rare neuromuscular diseases.